Comparative in vitro activity of tigecycline and other antimicrobial agents against Shigella species from Kuwait and the United Arab of Emirates

Journal of Infection and Public Health - Tập 3 - Trang 35-42 - 2010
Wafaa Jamal1, V.O. Rotimi1, T. Pal2, Agnes Sonnevend2, T.S. Dimitrov3
1Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
2Department of Microbiology and Immunology, University of UAE, Alin, United Arab Emirates
3Department of Microbiology, Infectious Diseases Hospital, Kuwait

Tài liệu tham khảo

Salam, 1991, Antimicrobial therapy for shigellosis, Rev Infect Dis, 13, S332, 10.1093/clinids/13.Supplement_4.S332 Bennish, 1992, Rethinking options for the treatment of shigellosis, J Antimicrob Chemother, 30, 243, 10.1093/jac/30.3.243 Nguyen, 2005, Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam, Antimicrob Agents Chemother, 49, 816, 10.1128/AAC.49.2.816-819.2005 Vasilev, 2004, Antimicrobial resistance of Shigella flexneri serotypes in Israel during a period of three years: 2000–2002, Epidemiol Infect, 132, 1049, 10.1017/S0950268804002912 Kim, 2004, Occurrence of extended-spectrum β-lactamases in members of the genus Shigella in the Republic of Korea, J Clin Microbiol, 42, 5264, 10.1128/JCM.42.11.5264-5269.2004 Clinical and Laboratory Standards Institute (CLSI): Performance Standard for Antimicrobial Susceptibility testing. Document M100-S15. Wayne (PA); 2005. Cao, 2002, CoIE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum β-lactamase CTX-M-17, Antimicrob Agents Chemother, 46, 1212, 10.1128/AAC.46.5.1212-1217.2002 Rotimi, 2008, Emergence of CTX-M-15-type extended-spectrum β-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates, J Med Microbiol, 57, 881, 10.1099/jmm.0.47509-0 Jamal, 1998, Prevalence and susceptibility of Shigella species to 11 antibiotics in a Kuwait teaching hospital, J Chemother, 10, 285, 10.1179/joc.1998.10.4.285 Jumaa, 2005, A survey of antimicrobial resistance in a tertiary referral hospital in the United Arab Emirates, J Chemother, 17, 376, 10.1179/joc.2005.17.4.376 Pazhani, 2005, Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India, Epidemiol Infect, 133, 1089, 10.1017/S0950268805004498 Karacan, 2007, Evaluation of shigellosis in a Turkish children's hospital, Pediatr Int, 49, 589, 10.1111/j.1442-200X.2007.02425.x Iwalokun, 2001, Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance, J Health Popul Nutr, 19, 183 Naik, 2006, Prevalence and antimicrobial susceptibility patterns of Shigella species in Asmara, Eritrea, Northeast Africa, J Microbiol Immunol Infect, 39, 392 Sivapalasingam, 2006, High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002, Antimicrob Agents Chemother, 50, 49, 10.1128/AAC.50.1.49-54.2006 Xiong, 2007, Detection of CTX-M-14 extended-spectrum β-lactamase in Shigella sonnei isolates from China, J Infect, 55, 125, 10.1016/j.jinf.2007.07.017 Streit, 2006, Int J Antimicrob Agents, 27, 367, 10.1016/j.ijantimicag.2005.12.004 Isenbarger, 2002, Comparative antibiotic resistance of diarrhoeal pathogens from Vietnam and Thailand, 1996–1999, Emerg Infect Dis, 8, 175, 10.3201/eid0802.010145 Agtini, 2005, The burden of diarrhoea, shigellosis and cholera in North Jakarta, Indonesia: findings from 24 months surveillance, BMC Infect Dis, 5, 89, 10.1186/1471-2334-5-89 Aarestrup, 2003, Is it time to change fluoroquinolone breakpoints for Salmonella spp.?, Antimicrob Agents Chemother, 47, 827, 10.1128/AAC.47.2.827-829.2003 Naheed, 2004, Flouroquinolone-resistant Shigella dysenteriae type I in Northeastern Bangladesh, Lancet Infect Dis, 4, 607, 10.1016/S1473-3099(04)01143-0 Sur, 2003, Multidrug-resistant Shigella dysenteriae type I: forerunners of a new epidemic strain in eastern India?, Emerg Infect Dis, 9, 404, 10.3201/eid0903.020352 Talukder, 2004, Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type I strains isolated in south Asia, J Antimicrob Chemother, 54, 730, 10.1093/jac/dkh425 Cheasty, 2004, Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy, Clin Microbiol Infect, 10, 1033, 10.1111/j.1469-0691.2004.00982.x Andres, 2005, Extended-spectrum β-lactamases in Shigella flexneri from Argentina: first report of TOHO-1 outside Japan, Int J Antimicrob Agents, 25, 501, 10.1016/j.ijantimicag.2005.02.016 Vasilev, 2007, Extended-spectrum β-lactamase-producing Shigella strains in Israel, 2000–2004, Eur J Clin Microbiol Infect Dis, 26, 189, 10.1007/s10096-007-0263-y Matar, 2007, First detection and sequence analysis of the blaCTX-M-15 gene in Lebanese isolates of extended-spectrum-β-lactamase-producing Shigella sonnei, Ann Trop Med Parasitol, 101, 511, 10.1179/136485907X193860 Kim, 2007, CTX-M extended-spectrum β-lactamases, Washington State, Emerg Infect Dis, 13, 513, 10.3201/eid1303.060479